Andrea Markkula

Publications
Public outreach and news

Articles

Article: EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2025;34(2):675-684
Paternal intelligence affects school grades in children with and without ADHD - a register-based study.
Markkula A; Igelström K; Zhang H; Capusan AJ
Article: CANCER CAUSES & CONTROL. 2019;30(11):1157-1170
The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer.
Tryggvadottir H; Ygland Rödström M; Markkula A; Kenéz X; Isaksson K; Borgquist S; Jernström H
Article: FRONTIERS IN ONCOLOGY. 2018;8:428
Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients.
Tryggvadottir H; Huzell L; Gustbée E; Simonsson M; Markkula A; Jirström K; Rose C; Ingvar C; Borgquist S; Jernström H
Article: ONCOTARGET. 2017;8(6):9093-9107
Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups.
Björner S; Rosendahl AH; Simonsson M; Markkula A; Jirström K; Borgquist S; Rose C; Ingvar C; Jernström H
Article: CLINICAL CANCER RESEARCH. 2017;23(3):766-777
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
Elebro K; Borgquist S; Rosendahl AH; Markkula A; Simonsson M; Jirström K; Rose C; Ingvar C; Jernström H
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;140(1):163-175
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.
Simonsson M; Björner S; Markkula A; Nodin B; Jirström K; Rose C; Borgquist S; Ingvar C; Jernström H
Article: FRONTIERS IN ENDOCRINOLOGY. 2017;8:332
Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer.
Björner S; Rosendahl AH; Simonsson M; Markkula A; Jirström K; Borgquist S; Rose C; Ingvar C; Jernström H
Article: BRITISH JOURNAL OF CANCER. 2016;115(3):382-390
Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort.
Persson M; Simonsson M; Markkula A; Rose C; Ingvar C; Jernström H
Article: BMC CANCER. 2016;16:256
CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.
Simonsson M; Veerla S; Markkula A; Rose C; Ingvar C; Jernström H
Article: CLINICAL CANCER RESEARCH. 2015;21(16):3640-3650
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort.
Elebro K; Borgquist S; Simonsson M; Markkula A; Jirström K; Ingvar C; Rose C; Jernström H
Article: CLINICAL CANCER RESEARCH. 2015;21(8):1877-1887
Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer.
Rosendahl AH; Perks CM; Zeng L; Markkula A; Simonsson M; Rose C; Ingvar C; Holly JMP; Jernström H
Article: BREAST CANCER RESEARCH AND TREATMENT. 2015;149(2):505-515
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
Huzell L; Persson M; Simonsson M; Markkula A; Ingvar C; Rose C; Jernström H
Article: BMC CLINICAL PATHOLOGY. 2015;15:8
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
Gustbée E; Tryggvadottir H; Markkula A; Simonsson M; Nodin B; Jirström K; Rose C; Ingvar C; Borgquist S; Jernström H
Article: INTERNATIONAL JOURNAL OF CANCER. 2014;135(8):1898-1910
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
Markkula A; Simonsson M; Rosendahl AH; Gaber A; Ingvar C; Rose C; Jernström H
Article: BMC CANCER. 2014;14:759
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
Markkula A; Simonsson M; Ingvar C; Rose C; Jernström H
Article: ACTA ONCOLOGICA. 2014;53(2):195-200
No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients.
Markkula A; Hjertberg M; Rose C; Ingvar C; Jernström H
Article: SPRINGERPLUS. 2014;3:261
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events.
Simonsson M; Markkula A; Bendahl P-O; Rose C; Ingvar C; Jernström H
Article: SPRINGERPLUS. 2013;2(1):298
Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events.
Gustbée E; Anesten C; Markkula A; Simonsson M; Rose C; Ingvar C; Jernström H
Article: CANCER CAUSES & CONTROL. 2012;23(8):1307-1316
Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort.
Markkula A; Bromée A; Henningson M; Hietala M; Ringberg A; Ingvar C; Rose C; Jernström H
Article: CANCER PREVENTION RESEARCH. 2012;5(5):735-745
Clinical profiles predict early nonadherence to adjuvant endocrine treatment in a prospective breast cancer cohort.
Markkula A; Hietala M; Henningson M; Ingvar C; Rose C; Jernström H

Articles

News from KI

Events from KI